Endogenous serotonin facilitates in vivo acetylcholine release in rat frontal cortex through 5-HT(1B) receptors

Journal of Pharmacology and Experimental Therapeutics

Volumn 277, Issue 2, 1996, Pages 823-830

  Consolo, S ^a   Arnaboldi, S ^a   Ramponi, S ^a   Nannini, L ^a   Ladinsky, H ^a   Baldi, G ^a  

^a Laboratory of Neuropharmacology   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

3 (1,2,5,6 TETRAHYDRO 4 PYRIDYL)PYRROLO[3,2 B]PYRIDIN 5 ONE; 3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; NORFENFLURAMINE; PINDOLOL; RITANSERIN; SEROTONIN; SEROTONIN RECEPTOR;

ACETYLCHOLINE RELEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FACILITATION; FRONTAL CORTEX; MICRODIALYSIS; NERVE DEGENERATION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; SEROTONINERGIC TRANSMISSION;

ACETYLCHOLINE; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FRONTAL LOBE; INDOLES; NORFENFLURAMINE; PYRIDINES; PYRROLES; RATS; RECEPTORS, SEROTONIN; RITANSERIN; SEROTONIN; SEROTONIN ANTAGONISTS; SULFONAMIDES; TETRODOTOXIN;

EID: 0030439664     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Ablad, B., Borg, K. O., Carlsson, E. Ek, E., Johnsson, G., Malmfors, T. and Regardh, C. G.: A survey of the pharmacological properties of metoprolol in animals and man. Acta Pharmacol. Toxicol. 36: (Suppl. V), 7-23, 1975.
2. Azmitla, E. C. and Segal, M.: An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J. Comp. Neurol. 179: 641-668, 1978.
3. Barone, D., Luzzani, F., Assandri, A., Galliani, G., Mennini, T. and Garattini, S.: In vivo stereospecific [3H]spiperone binding in rat brain: characteristic, regional distribution, kinetics and pharmacological properties. Eur. J. Pharmacol. 116: 63-74, 1985.
4. 3H]acetylcholine release from guinea-pig striatal slices. Br. J. Pharmacol. 97: 213-221, 1989.
5. 3 agonists decrease acetylcholine efflux from the cerebral cortex of freely-moving guinea-pigs. Br. J. Pharmacol. 101: 448-452, 1990.
6. 2-selective adrenoceptor antagonist (ICI 118,551). J. Cardio-vasc. Pharmacol. 5: 430-437, 1983.
7. Borroni, E., Ceci, A., Garattini, S. and Mennini, T.: Differences between d-fenfluramine and d-norfenfluramine in serotonin presynaptic mechanisms. J. Neurochem. 40: 891-893, 1983.
8. 125]iodotyrosinamide, a new radioiodinated probe for 5-HT1B and 5-HT1D binding sites. J. Neurochem. 58: 951-959, 1992.
9. Buzsaki, G. and Gage, F.: The cholinergic nucleus basal is: a key structure in neocortical arousal. In Central Cholinergic Synaptic Transmission, ed. by M. Frotscher and U. Misgeld, pp. 159-171, Birkhauser, Boston, 1989.
10. Celesia, G. G. and Jasper, H. H.: Acetylcholine released from cerebral cortex in relation to state of activation. Neurology 16: 1053-1063, 1966.
11. Consolo, S., Wu, C. F., Fiorentlni, F., Ladinsky, H. and Vezzani, A. M.: Determination of endogenous acetylcholine release in freely moving rats by trans-striatal dialysis coupled to a radioenzymatic assay: effect of drugs. J. Neurochem. 48: 1459-1465, 1987.
12. 3 receptors. Abs. Neurosci. 19: 724.4, 1993.
13. 3 receptors. J. Neurochem. 62: 2254-2261, 1994a.
14. 4 receptor stimulation facilitates acetylcholine release in rat frontal cortex. NeuroReport 5: 1230-1232, 1994b.
15. Consolo, S., Ramponi, S. Ladinsky, H. Baldi, G., and : A critical role for D, receptors in the 5-HT1A-mediated facilitation of in vivo acetylcholine release in rat frontal cortex. Brain Res. 707: 320-323, 1996.
16. Day, J., Damsma, G. and Fibiger, H. C: Cholinergic activity in the rat hip-pocampus, cortex and striatum correlates with locomotor activity: An in vivo microdialysis study. Pharm. Biochem. Behav. 38: 723-729, 1991.
17. Delacour, J., Bassant, M. H., Onofrj, M., Santucci, V. and Kleinlogel, H.: Electrophysiological models for the study of cognition enhancers. Pharmacopsychiatry 23: 90-93, 1990.
18. 1B binding sites. Naunyn Schmiedebergs Arch. Pharmacol. 332: 1-7, 1986.
19. Fletcher, A., Bill, D. J., Cuffe, I. A., Forster, E. A., Jones, D. and Really, Y.: A pharmacological profile of WAY-100635, a potent and selective 5-HT1A receptor antagonist. Br. J. Pharmacol. 112: 91P, 1994.
20. Garattini, S., Caccia, S., Mennini, T., Samanin, R., Consolo, S. and Ladinsky, H.: Biochemical pharmacology of the anorectic drug fenfluramine: A review. Curr. Med. Res. Opin. 6: 15-27, 1979.
21. Garattini, S.: Mechanism of the anorectic activity of dextrofenfluramine. In Body Weight Control, ed. by A. E. Bender and L. J. Brookers, pp. 261-270, Churchill, Livingstone, New York, 1987.
22. Gillet, G., Ammor, S. and Fillion, G.: Serotonin inhibits acetylcholine release from rat striatum slices: Evidence for a presynaptic receptor-mediated effect. J. Neurochem. 45: 1687-1691, 1985.
23. lA receptor antagonist WAY-100635 on hippocampal 5-HT release in vivo. Br. J. Pharmacol. 112: 299P, 1994.
24. Harel-Dupas, C, Cloez, I. and Fillion, G.: The inhibitory effect of trifluorom-ethylphenylpiperazine on [3H]acetylcholine release in guinea-pig hippocampal synaptosomes is mediated by a 5-hydroxytryptamine! receptor distinct from 1A, IB and 1C subtypes. J. Neurochem. 56: 221-227, 1991.
25. Hjorth, S. and Sharp, T.: In vivo microdialysis evidence for central serotonin 1A and serotonin IB autoreceptor blocking properties of the beta adrenoceptor antagonist (-)penbutolol. J. Pharmacol. Exp. Ther. 265: 707-712, 1993.
26. Hoyer, D.: Functional correlates of serotonin 5-HT! recognition sites. J. Re-cept. Res. 8: 59-81, 1988.
27. Hoyer, D., Clarke, D. E., Fozard, J. R., Hartig, P. R, Martin, G. R., Mylecha-rane, E. J., Saxena, P. R. and Humphrey, P. P. A.: International union of pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol. Rev. 46: 157-203, 1994.
28. Invernizzi, R., Kmieciak-Kolada, K and Samanin, R.: Is receptor activation involved in the mechanism by which ( + )-fenfluramine and (+)-norfenfluramine deplete 5-hydroxytryptamine in the rat brain?. Br. J. Pharmacol. 75: 525-530, 1982.
29. 1Breceptor. J. Biol. Chem. 267: 5735-5738, 1992.
30. Kanai T. and Szerb, J. C: Mesencephalic reticular activating system and cortical acetylcholine output. Nature 206: 80-82, 1965.
31. Khawaja, X.: Quantitative autoradiographic characterisation of the binding of [3H] WAY-100635, a selective 5-HT1A receptor antagonist. Brain Res. 673: 217-225, 1995.
32. Ladinsky, H., Borsini, F., Cortes, R., Palacios, J. M., Giorgi, S., Russi, G. and Consolo, S.: Serotonin-3 receptors control inhibition of acetylcholine release from frontal cortex and facilitation from dorsal hippocampus: A microdialy-sis study with 2-methylserotonin and DAU 6215. Soc. Neurosci. Abstr. 19: 724.5, 1993.
33. 1D in the rabbit and guinea-pig brain cortex. Naunyn Schmiede-bergs Arch. Pharmacol. 343: 353-364, 1991.
34. Macor, J. E., Burkhart, C. A., Heym, J. H., Ives, J. L., Lebel, L. A., Newman, M. E., Nielsen, J. A., Ryan, K., Schulz, D. W., Torgersen, L. K. and Koe, B. K: 3-(l,2,5,6-Tetrahydropyrid-4-yl) pyrrolo [3,2-b] pyrid-5-one: A potent and selective serotonin (5-HT1B) agonist and rotationally restricted phenolic analogue of 5-methoxy-3-(l,2,5,6-tetrahydropyrid-4-yl) indole. J. Med. Chem. 33: 2087-2093, 1990.
35. 1B receptors mediating inhibition of acetylcholine release. Eur. J. Pharmacol. 129: 333-337, 1986.
36. Maura, G., Fedele, E. and Ratteri, M.: Acetylcholine release from rat hip-pocampal slices is modulated by 5-hydroxytryptamine. Eur. J. Pharmacol. 166: 173-179, 1989.
37. Mennini, T., Borroni, E., Samanin, R. and Garattini, S.: Evidence of the existence of two different intraneuronal pools from which pharmacological agents can release serotonin. Neurochem. Int. 3: 289-294, 1981.
38. Mennini, T., Garattini, S. and Caccia, S.: Anorectic effect of fenfluramine isomers and metabolites: relationship between brain levels and in vitro potencies on serotoninergic mechanisms. Psychopharmacology (Berl) 86: 111-114, 1985.
39. Middlemiss, D. N., Neill, J. and Tricklebank, M. D.: Subtypes of the 5-HT receptor involved in hypothermia and forepaw treading induced by 8-OH-DPAT. Br. J. Pharmacol. 86: 251P, 1985.
40. Middlemiss, D. N., Bremer, M. E. and Smith, S. M.: A pharmacological analysis of the 5-HT receptors mediating inhibition of 5-HT release in the guinea-pig frontal cortex. Eur. J. Pharmacol. 167: 101-107, 1988.
41. Monsma, F. J., Shen, Y., Ward, R. P., Hambun, M. W. and Skley, D. R.: Cloning and expession of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. Mol. Pharmacol. 43: 320-327, 1993.
42. Palacios, J. M., Waeber, C, Bruinvels, A. T. and Hoyer, D.: Direct visualisation of 8erotonin1D receptors in the human brain using a new iodinated ligand. Mol. Brain Res. 13: 175-179, 1992.
43. Paxinos, G. and Watson, C: The Rat Brain in Stereotaxic Coordinates. Academic Press, Sydney, 1982.
44. Penttila, M., Partanen, J. V., Soininen, H. and Riekkinen, P. J.: Quantitative analysis of occipital EEG in different stages of Alzheimer's disease. Electro-encephalogr. Clin. Neurophysiol. 60:1-6, 1985.
45. QUIRION, R. and Richard, J.: Differential effects of selective lesions of cholinergic and dopaminergic neurons on serotonin-type 1 receptors in rat brain. Synapse 1: 124-130, 1987.
46. Rada, P. V., Mark, G. P. and Hoebel, B. G.: In vivo modulation of acetylcholine in the nucleus accumbens of freely moving rats: I. Inhibition by serotonin. Brain. Res. 619: 98-104, 1993.
47. Ratteri, M., Maura, G., Bonanno, G. and Pittaluga, A.: Differential pharmacology and function of two 5-HT! receptors modulating transmitter release in rat cerebellum. J. Pharmacol. Exp. Ther. 237: 644-648, 1986.
48. Riekkinen, P., Butzaki, G., Riekkinen, Jr., P., Soininen, H. and Partanen, J.: The cholinergic system and EEG slow waves. Electroencephalogr. Clin. Neurophysiol. 78: 89-96, 1991.
49. Robinson, S. E.: Effect of specific serotonergic lesions on cholinergic neurons in the hippocampus, cortex and striatum. Life Sci. 32: 345-353, 1983.
50. Schlicker, E., Fink, K, Gothert, M., Hoyer, D., Molderings, G., Roschke, I. and Schoeffter, P.: The pharmacological properties of the presynaptic 5-HT autoreceptor in the pig brain cortex conform to the 5-HT1D receptor subtype. Naunyn Schmiedebergs Arch. Pharmacol. 340: 45-51, 1989.
51. 1D binding sites in the central nervous system. CR Acad. Sci. (Paris) 312: 655-661, 1991.
52. Semba, K: The cholinergic basal forebrain: a critical role in cortical arousal. In The Basal Forebrain: Anatomy to Function, ed. by T. C. Napier, P. W. Kalivas and I. Hanin, pp. 197-218, Plenum Press, New York, 1992.
53. Shen, Y., Monsma, F. J., Metcalf, M. A., Jose, P. A., Hamblin, M. W. and Sibley, D. R.: Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype. J. Biol. Chem. 268:18200-18204, 1993.
54. 1A receptor agonist, on cortical acetylcholine release, electro-corticogram and body temperature in guinea pigs and rats. Eur. J. Pharmacol. 175: 219-223, 1990.
55. Szerb, J. C: Cortical acetylcholine release and electroencephalographic arousal. J. Physiol. 192: 329-343, 1967.
56. Vizi, E. S., Harsing, L. G. and Zsilla, G.: Evidence of the modulatory role of serotonin in acetylcholine release from striatal interneurones. Brain Res. 212: 89-99, 1981.
57. 1Breceptor. EMBO J. 10: 4017-4023, 1991.
58. 3H)-Ketan8erin (serotonin type-2) binding increases in rat cortex following basal forebrain lesions with ibotenic acid. J. Neurochem. 47: 845-350, 1986.
59. 1A receptor activation increases hippocampal acetylcholine efflux and motor activity in the guinea pig: agonist efficacy influences functional activity in vivo. J. Pharmacol. Exp. Ther. 270: 656-663, 1994.
60. Wu, C. F., Bertorelli, R., Sacconi, M., Pepeu, G. and Consolo, S.: Decrease of brain acetylcholine release in aging freely-moving rats detected by microdialysis. Neurobiol. Aging 9: 357-361, 1988.
61. ZIFA, E. and Fillion, G.: 5-hydroxytriptamine receptors. Pharmacol. Rev. 44: 401-457, 1992.